Iovance Biotherapeutics, Inc.

IOVANASDAQHealthcare● Active

$4.05

$-0.19(-4.37%)

Market Cap$1.4B

P/E Ratio—

52W High$5.63

52W Low$1.66

Avg Volume15.6M

Open$4.29

Beta0.70

Insider Trades Ownership Employees

Iovance Biotherapeutics, Inc.（IOVA）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · IOVA · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

中性

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Iovance Biotherapeutics, Inc.内部人在过去近12个月买卖活动混合。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

IOVA 季度内部人买卖趋势

IOVA 内幕交易卖出 · IOVA 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.4M696K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · IOVA CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

IOVA 高管卖出股份 · IOVA 董事内幕交易 · SEC Form 4申报

显示最近 52 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jun 1, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	41,668	—	—	571,206	Form 4
Jun 1, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	17,701	$3.96	$70K	553,505	Form 4
Jun 1, 2026	Puri Raj K. Chief Regulatory Officer	Option	5,469	—	—	244,699	Form 4
Jun 1, 2026	Puri Raj K. Chief Regulatory Officer	Other	2,508	$3.96	$10K	242,191	Form 4
Jun 1, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	8,790	—	—	140,747	Form 4
Jun 1, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Other	4,473	$3.96	$18K	136,274	Form 4
Jun 1, 2026	BILINSKY IGOR COO	Option	8,790	—	—	134,556	Form 4
Jun 1, 2026	BILINSKY IGOR COO	Other	4,473	$3.96	$18K	130,083	Form 4
May 11, 2026	Kirby Daniel Gordon Chief Commercial Officer	Option	10,000	—	—	149,381	Form 4
May 11, 2026	Kirby Daniel Gordon Chief Commercial Officer	Other	2,435	$3.70	$9K	146,946	Form 4
Mar 5, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	62,493	—	—	556,293	Form 4
Mar 5, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	26,755	$4.58	$123K	529,538	Form 4
Mar 5, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	31,246	—	—	148,477	Form 4
Mar 5, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Other	16,520	$4.58	$76K	131,957	Form 4
Mar 5, 2026	Puri Raj K. Chief Regulatory Officer	Option	39,059	—	—	257,590	Form 4
Mar 5, 2026	Puri Raj K. Chief Regulatory Officer	Other	18,360	$4.58	$84K	239,230	Form 4
Mar 5, 2026	BILINSKY IGOR COO	Option	31,246	—	—	142,394	Form 4
Mar 5, 2026	BILINSKY IGOR COO	Other	16,628	$4.58	$76K	125,766	Form 4
Mar 2, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	52,087	—	—	516,609	Form 4
Mar 2, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	22,809	$3.79	$86K	493,800	Form 4
Mar 2, 2026	BILINSKY IGOR COO	Option	12,307	—	—	118,051	Form 4
Mar 2, 2026	BILINSKY IGOR COO	Other	6,903	$3.79	$26K	111,148	Form 4
Mar 2, 2026	Puri Raj K. Chief Regulatory Officer	Option	5,470	—	—	221,329	Form 4
Mar 2, 2026	Puri Raj K. Chief Regulatory Officer	Other	2,798	$3.79	$11K	218,531	Form 4
Mar 2, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	12,697	—	—	124,353	Form 4

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

日期

Jun 1

股数

41,668

均价

—

总金额

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

日期

Jun 1

股数

17,701

均价

$3.96

总金额

$70K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

日期

Jun 1

股数

5,469

均价

—

总金额

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

日期

Jun 1

股数

2,508

均价

$3.96

总金额

$10K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

日期

Jun 1

股数

8,790

均价

—

总金额

—

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Other

日期

Jun 1

股数

4,473

均价

$3.96

总金额

$18K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

日期

Jun 1

股数

8,790

均价

—

总金额

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

日期

Jun 1

股数

4,473

均价

$3.96

总金额

$18K

View Form 4 on SEC.gov

Kirby Daniel Gordon

Chief Commercial Officer

Option

日期

May 11

股数

10,000

均价

—

总金额

—

View Form 4 on SEC.gov

Kirby Daniel Gordon

Chief Commercial Officer

Other

日期

May 11

股数

2,435

均价

$3.70

总金额

$9K

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

日期

Mar 5

股数

62,493

均价

—

总金额

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

日期

Mar 5

股数

26,755

均价

$4.58

总金额

$123K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

日期

Mar 5

股数

31,246

均价

—

总金额

—

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Other

日期

Mar 5

股数

16,520

均价

$4.58

总金额

$76K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

日期

Mar 5

股数

39,059

均价

—

总金额

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

日期

Mar 5

股数

18,360

均价

$4.58

总金额

$84K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

日期

Mar 5

股数

31,246

均价

—

总金额

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

日期

Mar 5

股数

16,628

均价

$4.58

总金额

$76K

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

日期

Mar 2

股数

52,087

均价

—

总金额

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

日期

Mar 2

股数

22,809

均价

$3.79

总金额

$86K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

日期

Mar 2

股数

12,307

均价

—

总金额

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

日期

Mar 2

股数

6,903

均价

$3.79

总金额

$26K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

日期

Mar 2

股数

5,470

均价

—

总金额

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

日期

Mar 2

股数

2,798

均价

$3.79

总金额

$11K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

日期

Mar 2

股数

12,697

均价

—

总金额

—

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 IOVA 内幕交易

IOVA 内幕交易

Iovance Biotherapeutics, Inc.（IOVA）内幕交易数据来源于公司内部人（包括Vogt Frederick G (Interim CEO & General Counsel · Director), GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer), BILINSKY IGOR (COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IOVA内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Iovance Biotherapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

IOVA 内幕交易 · 5个问题

Iovance Biotherapeutics, Inc.（IOVA）的内部人包括高管和董事，如Vogt Frederick G (Interim CEO & General Counsel · Director), GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer), BILINSKY IGOR (COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

IOVA 董事内幕交易IOVA 内部人名单Iovance Biotherapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026